Doctor of Medicine, Chief Physician, Director of the Department of Nephrology, Executive Deputy Director of the Rare Disease Diagnosis and Treatment Center, and Deputy Director of the Internal Medicine Teaching and Research Section. He joined the Rare and Complex Disease Clinic Team of Shanghai Children's Medical Center in 2011, and was responsible for the quarterly remote consultation program between SCMC and Comer Children's Hospital in Chicago. He is the associate editor of *Treatable Rare Diseases*, the first clinical monograph on rare diseases in China.

Overseas training experience: He has studied at the Department of Nephrology at Royal Children's Hospital in Melbourne, Australia, as well as the Department of Nephrology and Rheumatology at Cincinnati Children's Hospital Medical Center in the United States. His training covered the treatment of refractory nephropathy and autoimmune diseases in children, diagnosis and management of autoinflammatory diseases, application of biological agents, management of pediatric hypertension, and care of children receiving hemodialysis and renal transplantation.

Main research interests: Pathogenesis of primary nephrotic syndrome in children and treatment of refractory nephropathy. He has published more than 20 papers in SCI-indexed journals and Chinese statistical source core journals.

He specializes in the diagnosis and treatment of pediatric renal and autoimmune diseases, including complicated urinary tract infections in infants, refractory nephrotic syndrome, IgA nephropathy, acute kidney injury, pediatric hypertension, hyperuricemia, renal tubular diseases, lupus nephritis, purpura nephritis, Takayasu arteritis, thrombotic microangiopathy, macrophage activation syndrome, juvenile idiopathic arthritis, and dermatomyositis. He has accumulated extensive clinical experience in diagnosing rare and complex pediatric diseases.